Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 400

1.

A behavioral economic analysis of the effects of rimcazole on reinforcing effects of cocaine injection and food presentation in rats.

Job MO, Katz JL.

Psychopharmacology (Berl). 2019 Dec;236(12):3601-3612. doi: 10.1007/s00213-019-05332-x. Epub 2019 Aug 9.

PMID:
31399853
2.

Extraversion modulates cortisol responses to acute social stress in chronic major depression.

Chopra K, Katz JL, Quilty LC, Matthews S, Ravindran A, Levitan RD.

Psychoneuroendocrinology. 2019 May;103:316-323. doi: 10.1016/j.psyneuen.2019.02.008. Epub 2019 Feb 8.

PMID:
30784994
3.

A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids.

Yue K, Tanda G, Katz JL, Zanettini C.

Behav Pharmacol. 2019 Feb 7. doi: 10.1097/FBP.0000000000000474. [Epub ahead of print]

PMID:
30741729
4.

Vigilance demand and the effects of stimulant drugs in a five-choice reaction-time procedure in mice.

Katz JL, Kohut SJ, Soto P.

Behav Pharmacol. 2018 Dec;29(8):701-708. doi: 10.1097/FBP.0000000000000435.

5.

Abuse liability of mitragynine assessed with a self-administration procedure in rats.

Yue K, Kopajtic TA, Katz JL.

Psychopharmacology (Berl). 2018 Oct;235(10):2823-2829. doi: 10.1007/s00213-018-4974-9. Epub 2018 Jul 23.

PMID:
30039246
6.

Dopamine Transporter Dynamics of N-Substituted Benztropine Analogs with Atypical Behavioral Effects.

Hong WC, Wasko MJ, Wilkinson DS, Hiranita T, Li L, Hayashi S, Snell DB, Madura JD, Surratt CK, Katz JL.

J Pharmacol Exp Ther. 2018 Sep;366(3):527-540. doi: 10.1124/jpet.118.250498. Epub 2018 Jun 26.

7.

Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents.

Slezak JM, Mueller M, Ricaurte GA, Katz JL.

Behav Pharmacol. 2018 Sep;29(6):551-556. doi: 10.1097/FBP.0000000000000409.

8.

Poly(meta-phenylene oxides) for the design of a tunable, efficient, and reusable catalytic platform.

Hudson R, Zhang HR, LoTemplio A, Benedetto G, Hamasaka G, Yamada YMA, Katz JL, Uozumi Y.

Chem Commun (Camb). 2018 Mar 15;54(23):2878-2881. doi: 10.1039/c8cc00774h.

PMID:
29493698
9.

Punishment and the potential for negative reinforcement with histamine injection.

Mayer PCM, de Carvalho Neto MB, Katz JL.

J Exp Anal Behav. 2018 Mar;109(2):365-379. doi: 10.1002/jeab.319. Epub 2018 Feb 27.

PMID:
29485718
10.

Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats.

Zanettini C, Wilkinson DS, Katz JL.

Psychopharmacology (Berl). 2018 Jan;235(1):47-58. doi: 10.1007/s00213-017-4739-x. Epub 2017 Sep 21.

PMID:
28932889
11.

The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.

Hong WC, Yano H, Hiranita T, Chin FT, McCurdy CR, Su TP, Amara SG, Katz JL.

J Biol Chem. 2017 Jul 7;292(27):11250-11261. doi: 10.1074/jbc.M116.774075. Epub 2017 May 11.

12.

σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration.

Hiranita T, Hong WC, Kopajtic T, Katz JL.

J Pharmacol Exp Ther. 2017 Jul;362(1):2-13. doi: 10.1124/jpet.117.241109. Epub 2017 Apr 25.

13.

Modulation of opioid receptor affinity and efficacy via N-substitution of 9β-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.

Truong PM, Hassan SA, Lee YS, Kopajtic TA, Katz JL, Chadderdon AM, Traynor JR, Deschamps JR, Jacobson AE, Rice KC.

Bioorg Med Chem. 2017 Apr 15;25(8):2406-2422. doi: 10.1016/j.bmc.2017.02.064. Epub 2017 Mar 1.

14.

Histomorphometric Comparison of Transmandibular Implant and Titanium Implant.

Nomura T, Powers MP, Katz JL, Ejiri S, Kobayashi T.

J Long Term Eff Med Implants. 2016;26(3):209-215. doi: 10.1615/JLongTermEffMedImplants.2016016210.

PMID:
28134603
15.

A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.

Katz JL, Hiranita T, Hong WC, Job MO, McCurdy CR.

Handb Exp Pharmacol. 2017;244:177-218. doi: 10.1007/164_2016_94. Review.

PMID:
28110353
16.

Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption.

Slezak JM, Desai RI, Katz JL.

Behav Pharmacol. 2017 Feb;28(1):74-82. doi: 10.1097/FBP.0000000000000278.

17.

Rapid and sustained antidepressant properties of an NMDA antagonist/monoamine reuptake inhibitor identified via transporter-based virtual screening.

Talbot JN, Geffert LM, Jorvig JE, Goldstein RI, Nielsen CL, Wolters NE, Amos ME, Munro CA, Dallman E, Mereu M, Tanda G, Katz JL, Indarte M, Madura JD, Choi H, Leak RK, Surratt CK.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:22-30. doi: 10.1016/j.pbb.2016.08.007. Epub 2016 Aug 26.

PMID:
27569602
18.

The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.

Mereu M, Chun LE, Prisinzano TE, Newman AH, Katz JL, Tanda G.

Eur J Neurosci. 2017 Jan;45(1):167-174. doi: 10.1111/ejn.13376. Epub 2016 Sep 11.

19.

Lack of Specific Involvement of (+)-Naloxone and (+)-Naltrexone on the Reinforcing and Neurochemical Effects of Cocaine and Opioids.

Tanda G, Mereu M, Hiranita T, Quarterman JC, Coggiano M, Katz JL.

Neuropsychopharmacology. 2016 Oct;41(11):2772-81. doi: 10.1038/npp.2016.91. Epub 2016 Jun 14.

20.

Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists.

Katz JL, Hiranita T, Kopajtic TA, Rice KC, Mesangeau C, Narayanan S, Abdelazeem AH, McCurdy CR.

J Pharmacol Exp Ther. 2016 Jul;358(1):109-24. doi: 10.1124/jpet.116.232728. Epub 2016 Apr 21.

21.

Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.

Freyberg Z, Sonders MS, Aguilar JI, Hiranita T, Karam CS, Flores J, Pizzo AB, Zhang Y, Farino ZJ, Chen A, Martin CA, Kopajtic TA, Fei H, Hu G, Lin YY, Mosharov EV, McCabe BD, Freyberg R, Wimalasena K, Hsin LW, Sames D, Krantz DE, Katz JL, Sulzer D, Javitch JA.

Nat Commun. 2016 Feb 16;7:10652. doi: 10.1038/ncomms10652.

22.

2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations.

Hong WC, Kopajtic TA, Xu L, Lomenzo SA, Jean B, Madura JD, Surratt CK, Trudell ML, Katz JL.

J Pharmacol Exp Ther. 2016 Mar;356(3):624-34. doi: 10.1124/jpet.115.230722. Epub 2016 Jan 14.

23.

A role for sigma receptors in stimulant self-administration and addiction.

Katz JL, Hong WC, Hiranita T, Su TP.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):100-15. doi: 10.1097/FBP.0000000000000209. Review.

24.

Contributions to drug abuse research of Steven R. Goldberg's behavioral analysis of stimulus-stimulus contingencies.

Katz JL.

Psychopharmacology (Berl). 2016 May;233(10):1921-32. doi: 10.1007/s00213-015-4149-x. Epub 2015 Nov 13. Review.

PMID:
26564234
25.

Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area.

Kuo CC, Shen H, Harvey BK, Yu SJ, Kopajtic T, Hinkle JJ, Kyrkanides S, Katz JL, Wang Y.

Psychopharmacology (Berl). 2016 Feb;233(4):661-72. doi: 10.1007/s00213-015-4134-4. Epub 2015 Nov 10.

PMID:
26554386
26.

Dopamine D₂-Like Receptors and Behavioral Economics of Food Reinforcement.

Soto PL, Hiranita T, Xu M, Hursh SR, Grandy DK, Katz JL.

Neuropsychopharmacology. 2016 Mar;41(4):971-8. doi: 10.1038/npp.2015.223. Epub 2015 Jul 24.

27.

Erratum to: behavioral economics of food reinforcement and the effects of prefeeding, extinction, and eticlopride in dopamine D₂ receptor mutant mice.

Soto PL, Grandy DK, Hursh SR, Katz JL.

Psychopharmacology (Berl). 2015 May;232(9):1669. doi: 10.1007/s00213-015-3918-x. No abstract available.

PMID:
25814138
28.

DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling.

Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA, Pomrenze MB, Galer EL, Kopajtic TA, Li CM, Amat J, Larson G, Cooper DC, Huang Y, O'Neill CE, Yin H, Zahniser NR, Katz JL, Rice KC, Maier SF, Bachtell RK, Watkins LR.

Mol Psychiatry. 2015 Dec;20(12):1525-37. doi: 10.1038/mp.2014.177. Epub 2015 Feb 3.

29.

Synthesis of indoles, benzofurans, and related heterocycles via an acetylene-activated SNAr/intramolecular cyclization cascade sequence in water or DMSO.

Hudson R, Bizier NP, Esdale KN, Katz JL.

Org Biomol Chem. 2015 Feb 28;13(8):2273-84. doi: 10.1039/c4ob02549k.

PMID:
25608594
30.

Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.

Reith ME, Blough BE, Hong WC, Jones KT, Schmitt KC, Baumann MH, Partilla JS, Rothman RB, Katz JL.

Drug Alcohol Depend. 2015 Feb 1;147:1-19. doi: 10.1016/j.drugalcdep.2014.12.005. Epub 2014 Dec 18. Review.

31.

Simple but precise engineering of functional nanocapsules through nanoprecipitation.

Yan X, Delgado M, Fu A, Alcouffe P, Gouin SG, Fleury E, Katz JL, Ganachaud F, Bernard J.

Angew Chem Int Ed Engl. 2014 Jul 1;53(27):6910-3. doi: 10.1002/anie.201402825. Epub 2014 May 26.

PMID:
24862553
32.

Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine.

Kohut SJ, Hiranita T, Hong SK, Ebbs AL, Tronci V, Green J, Garcés-Ramírez L, Chun LE, Mereu M, Newman AH, Katz JL, Tanda G.

Biol Psychiatry. 2014 Nov 15;76(10):802-9. doi: 10.1016/j.biopsych.2014.03.031. Epub 2014 Apr 19.

33.

Single step synthesis of acetylene-substituted oxacalix[4]arenes.

Wackerly JW, Zhang M, Nodder ST, Carlin SM, Katz JL.

Org Lett. 2014 Jun 6;16(11):2920-2. doi: 10.1021/ol5010627. Epub 2014 May 15.

PMID:
24831553
34.

Choice for response alternatives differing in reinforcement frequency in dopamine D2 receptor mutant and Swiss-Webster mice.

Soto PL, Hiranita T, Grandy DK, Katz JL.

Psychopharmacology (Berl). 2014 Aug;231(16):3169-77. doi: 10.1007/s00213-014-3495-4. Epub 2014 Feb 28.

PMID:
24682471
35.

2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.

Hiranita T, Wilkinson DS, Hong WC, Zou MF, Kopajtic TA, Soto PL, Lupica CR, Newman AH, Katz JL.

J Pharmacol Exp Ther. 2014 May;349(2):297-309. doi: 10.1124/jpet.113.212738. Epub 2014 Feb 11. Erratum in: J Pharmacol Exp Ther. 2014 Jun 1;349(3):534.

36.

Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues.

Okunola-Bakare OM, Cao J, Kopajtic T, Katz JL, Loland CJ, Shi L, Newman AH.

J Med Chem. 2014 Feb 13;57(3):1000-13. doi: 10.1021/jm401754x. Epub 2014 Feb 4.

37.

Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites.

Banala AK, Zhang P, Plenge P, Cyriac G, Kopajtic T, Katz JL, Loland CJ, Newman AH.

J Med Chem. 2013 Dec 12;56(23):9709-24. doi: 10.1021/jm4014136. Epub 2013 Dec 2.

38.

Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist.

Desai RI, Grandy DK, Lupica CR, Katz JL.

J Pharmacol Exp Ther. 2014 Jan;348(1):106-15. doi: 10.1124/jpet.113.208538. Epub 2013 Nov 5.

39.

Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats.

Hiranita T, Kohut SJ, Soto PL, Tanda G, Kopajtic TA, Katz JL.

J Pharmacol Exp Ther. 2014 Jan;348(1):174-91. doi: 10.1124/jpet.113.208264. Epub 2013 Nov 5.

40.
41.

Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats.

Slezak JM, Ricaurte GA, Tallarida RJ, Katz JL.

Psychopharmacology (Berl). 2014 Jan;231(1):191-8. doi: 10.1007/s00213-013-3220-8. Epub 2013 Aug 24.

PMID:
23975034
42.

Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice.

Mereu M, Tronci V, Chun LE, Thomas AM, Green JL, Katz JL, Tanda G.

Addict Biol. 2015 Jan;20(1):91-103. doi: 10.1111/adb.12080. Epub 2013 Aug 4.

43.

Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats.

Hiranita T, Soto PL, Tanda G, Kopajtic TA, Katz JL.

J Pharmacol Exp Ther. 2013 Oct;347(1):20-9. doi: 10.1124/jpet.113.207522. Epub 2013 Aug 1.

44.

An alternative role for acetylenes: activation of fluorobenzenes toward nucleophilic aromatic substitution.

Bizier NP, Wackerly JW, Braunstein ED, Zhang M, Nodder ST, Carlin SM, Katz JL.

J Org Chem. 2013 Jun 21;78(12):5987-98. doi: 10.1021/jo400668v. Epub 2013 Jun 10.

PMID:
23692440
45.

Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change.

Tanda G, Li SM, Mereu M, Thomas AM, Ebbs AL, Chun LE, Tronci V, Green JL, Zou MF, Kopajtic TA, Newman AH, Katz JL.

Psychopharmacology (Berl). 2013 Sep;229(2):307-21. doi: 10.1007/s00213-013-3109-6. Epub 2013 Apr 24.

46.

Interactions of cocaine with dopamine D₂-like antagonists in squirrel monkeys.

Soto PL, Katz JL.

Psychopharmacology (Berl). 2013 Mar;226(2):393-400. doi: 10.1007/s00213-012-2914-7. Epub 2012 Nov 29.

PMID:
23192312
47.

Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.

Hiranita T, Mereu M, Soto PL, Tanda G, Katz JL.

Neuropsychopharmacology. 2013 Mar;38(4):605-15. doi: 10.1038/npp.2012.224. Epub 2012 Nov 28.

48.

The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration.

Li L, Hiranita T, Hayashi S, Newman AH, Katz JL.

Psychopharmacology (Berl). 2013 Feb;225(3):733-42. doi: 10.1007/s00213-012-2862-2. Epub 2012 Sep 14.

49.

Opioid activation of toll-like receptor 4 contributes to drug reinforcement.

Hutchinson MR, Northcutt AL, Hiranita T, Wang X, Lewis SS, Thomas J, van Steeg K, Kopajtic TA, Loram LC, Sfregola C, Galer E, Miles NE, Bland ST, Amat J, Rozeske RR, Maslanik T, Chapman TR, Strand KA, Fleshner M, Bachtell RK, Somogyi AA, Yin H, Katz JL, Rice KC, Maier SF, Watkins LR.

J Neurosci. 2012 Aug 15;32(33):11187-200.

50.

R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.

Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH.

Biol Psychiatry. 2012 Sep 1;72(5):405-13. doi: 10.1016/j.biopsych.2012.03.022. Epub 2012 Apr 25.

Supplemental Content

Support Center